Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.

Nguyen, Linda; Lucke-Wold, Brandon P; Mookerjee, Shona; Kaushal, Nidhi; Matsumoto, Rae R

Nguyen, Linda; Lucke-Wold, Brandon P; Mookerjee, Shona; Kaushal, Nidhi; Matsumoto, Rae R.

Afiliação

Nguyen L; Department of Behavioral Medicine and Psychiatry, School of Medicine, West Virginia University, 930 Chestnut Ridge Road, Morgantown, WV, 26506, USA.
Lucke-Wold BP; Department of Pharmaceutical Sciences, School of Pharmacy, One Medical Center, West Virginia University, Morgantown, WV, 26506, USA.
Mookerjee S; Graduate Program in Neuroscience, School of Medicine, West Virginia University, One Medical Center Drive, Morgantown, WV, 26506, USA.
Kaushal N; College of Pharmacy, Touro University California, 1310 Club Drive, Vallejo, CA, 94592, USA.
Matsumoto RR; Takeda California, Inc., San Diego, CA, 92121, USA.

Adv Exp Med Biol ; 964: 133-152, 2017.

Article em En | MEDLINE | ID: mdl-28315269

Assuntos

Chaperonas Moleculares/farmacologia; Doenças Neurodegenerativas/metabolismo; Fármacos Neuroprotetores/farmacologia; Receptores sigma/metabolismo; Animais; Encéfalo/efeitos dos fármacos; Encéfalo/metabolismo; Humanos; Ligantes; Doenças Neurodegenerativas/tratamento farmacológico; Neuroproteção/efeitos dos fármacos; Receptor Sigma-1

Palavras-chave

Alzheimer's disease; Amyotrophic lateral sclerosis; Neurorestoration; Parkinson's disease; Stroke

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores sigma / Fármacos Neuroprotetores / Chaperonas Moleculares / Doenças Neurodegenerativas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google